Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net income	$ 370,502	$ 402,963
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	435,342	424,797
Loss on sale of depreciable real estate assets	25	61
Gain on sale of non-depreciable real estate assets	0	(54)
Gain on consolidation of third-party development	(11,033)	0
Loss on embedded derivative in preferred shares	14,451	1,863
Stock compensation expense	12,396	12,296
Amortization of debt issuance costs, discounts and premiums	4,568	4,537
Gain on investments	(3,666)	(745)
Net change in operating accounts and other operating activities	36,580	26,538
Net cash provided by operating activities	859,165	872,256
Cash flows from investing activities:
Purchases of real estate and other assets	(189,104)	(12,450)
Capital improvements and other	(235,856)	(261,069)
Development costs	(255,216)	(151,145)
Distributions from real estate joint venture	284	0
Contributions to affiliates	(1,874)	(7,505)
Proceeds from sale of marketable equity securities	9,975	0
Proceeds from real estate asset dispositions	0	2,948
Net proceeds from insurance recoveries	20,203	680
Net cash used in investing activities	(651,588)	(428,541)
Cash flows from financing activities:
Net payments of commercial paper	(5,000)	(20,000)
Proceeds from notes payable	744,551	0
Principal payments on notes payable	(400,000)	(3,861)
Payment of deferred financing costs	(7,150)	0
Distributions to noncontrolling interests	(13,739)	(13,266)
Dividends paid on common shares	(515,085)	(488,354)
Dividends paid on preferred shares	(2,766)	(2,766)
Proceeds from issuances of common shares	955	204,743
Net change in other financing activities	(373)	(5,945)
Net cash used in financing activities	(198,607)	(329,449)
Net increase in cash, cash equivalents and restricted cash	8,970	114,266
Cash, cash equivalents and restricted cash, beginning of period	55,091	61,071
Cash, cash equivalents and restricted cash, end of period	64,061	175,337
Reconciliation of cash, cash equivalents and restricted cash at period end:
Cash and cash equivalents	50,232	161,897
Restricted cash	13,829	13,440
Total cash, cash equivalents and restricted cash	64,061	175,337
Supplemental information:
Interest paid	126,502	105,640
Income taxes paid	3,273	3,824
Non-cash transactions:
Distribution on common units declared and accrued	176,335	167,768
Accrued construction in progress	39,047	26,519
Interest capitalized	12,188	9,065
Conversion of OP Units to shares of common stock	3,529	894
Limited Partnership [Member]
Cash flows from operating activities:
Net income	370,502	402,963
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	435,342	424,797
Loss on sale of depreciable real estate assets	25	61
Gain on sale of non-depreciable real estate assets	0	(54)
Gain on consolidation of third-party development	(11,033)	0
Loss on embedded derivative in preferred shares	14,451	1,863
Stock compensation expense	12,396	12,296
Amortization of debt issuance costs, discounts and premiums	4,568	4,537
Gain on investments	(3,666)	(745)
Net change in operating accounts and other operating activities	36,580	26,538
Net cash provided by operating activities	859,165	872,256
Cash flows from investing activities:
Purchases of real estate and other assets	(189,104)	(12,450)
Capital improvements and other	(235,856)	(261,069)
Development costs	(255,216)	(151,145)
Distributions from real estate joint venture	284	0
Contributions to affiliates	(1,874)	(7,505)
Proceeds from sale of marketable equity securities	9,975	0
Proceeds from real estate asset dispositions	0	2,948
Net proceeds from insurance recoveries	20,203	680
Net cash used in investing activities	(651,588)	(428,541)
Cash flows from financing activities:
Net payments of commercial paper	(5,000)	(20,000)
Proceeds from notes payable	744,551	0
Principal payments on notes payable	(400,000)	(3,861)
Payment of deferred financing costs	(7,150)	0
Dividends paid on common shares	(528,824)	(501,620)
Dividends paid on preferred shares	(2,766)	(2,766)
Proceeds from issuances of common shares	955	204,743
Net change in other financing activities	(373)	(5,945)
Net cash used in financing activities	(198,607)	(329,449)
Net increase in cash, cash equivalents and restricted cash	8,970	114,266
Cash, cash equivalents and restricted cash, beginning of period	55,091	61,071
Cash, cash equivalents and restricted cash, end of period	64,061	175,337
Reconciliation of cash, cash equivalents and restricted cash at period end:
Cash and cash equivalents	50,232	161,897
Restricted cash	13,829	13,440
Total cash, cash equivalents and restricted cash	64,061	175,337
Supplemental information:
Interest paid	126,502	105,640
Income taxes paid	3,273	3,824
Non-cash transactions:
Distribution on common units declared and accrued	176,335	167,768
Accrued construction in progress	39,047	26,519
Interest capitalized	$ 12,188	$ 9,065